Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Journal Volume
32
Journal Issue
5
Date Issued
2023-05-01
Author(s)
Argirion, Ilona
Pfeiffer, Ruth M
Proietti, Carla
Coghill, Anna E
Yu, Kelly J
Middeldorp, Jaap M
Sarathkumara, Yomani D
Hsu, Wan-Lun
Chien, Yin-Chu
Rothman, Nathaniel
Lan, Qing
Chen, Chien-Jen
Mbulaiteye, Sam M
Jarrett, Ruth F
Glimelius, Ingrid
Smedby, Karin E
Hjalgrim, Henrik
Hildesheim, Allan
Doolan, Denise L
Liu, Zhiwei
Abstract
Epstein-Barr virus (EBV) is linked to multiple cancers, including classical Hodgkin lymphoma (cHL), endemic Burkitt lymphoma (eBL), nasopharyngeal carcinoma (NPC), and extranodal natural killer/T-cell lymphoma (NKTCL).
Type
journal article